Cullinan Associates’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$333K Buy
2,554
+54
+2% +$8.08K 0.03% 182
2026
Q2
$381K Hold
2,500
– – 0.03% 176
2026
Q1
$525K Buy
+2,500
New +$628K 0.04% 154

Other funds holding PODD

Cullinan Associates's PODD Position: Q3 2026 in Review

Cullinan Associates increased its Insulet (PODD) stake by 2.2% in Q3 2026, buying an estimated $8.08K and bringing the position to 2,554 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #182.

Cullinan Associates first reported a position in PODD in Q1 2026 and has held it in 3 quarters since. The position peaked at $525K in Q1 2026. 626 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Cullinan Associates held 2,554 shares of Insulet worth $333K as of Q3 2026.
  • Cullinan Associates bought 54 Insulet shares in Q3 2026, an estimated $8.08K.
  • Insulet made up 0.03% of Cullinan Associates's portfolio in Q3 2026, its #182 holding.
  • Cullinan Associates first reported a position in Insulet in Q1 2026 and has held it in 3 quarters since.
  • Cullinan Associates's Insulet position peaked at $525K in Q1 2026.
  • 626 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Cullinan Associates's 13F filing for Q3 2026, filed 3 Nov 2026.